Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |